Peptide record

TPDB18749

Antibacterial Anticancer Antiviral standard
61 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18749
Antibacterial Anticancer Antiviral
Anti-infective peptides Cancer-related peptides
Peptipedia dbAMP 3.0 DRAVP 2.0
standard
No
A 61-aa standard-residue multi-activity (Antibacterial, Anticancer, and Antiviral) peptide sequence curated from Peptipedia, dbAMP 3.0, and DRAVP 2.0, with an available 3D structural model.
Sequence
EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C327H539N101O93S1
NCGT
L
7405.56
9.95
14
11
27
+2
3.10
-0.741
102.46
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
6990
0.94
9
Residue Composition
number
7
A
9
R
0
N
4
D
0
C
7
E
6
Q
0
G
1
H
1
I
11
L
4
K
1
M
2
F
1
P
2
S
0
T
1
W
1
Y
3
V
Amino Acid Distribution
A: 7 R: 9 N: 0 D: 4 C: 0 E: 7 Q: 6 G: 0 H: 1 I: 1 L: 11 K: 4 M: 1 F: 2 P: 1 S: 2 T: 0 W: 1 Y: 1 V: 3
Chemical Descriptors
61 reviewed residue count
C327H539N101O93S1 sequence-only estimate (linear, free termini)
7405.56 sequence-only estimate (linear, free termini)
9.95 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
3.10 sequence-only estimate (linear, free termini)
-0.741 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

dbAMP 3.0 DRAVP 2.0